In an effort to expand and diversify its product offering and R&D pipeline, SPL has placed great importance in its corporate development program which consists of equity investment, partnering and collaboration, and technology and product in-licensing, etc.

We continually seek new partners that are actively researching new scientific ideas, capabilities and technologies that fit with our strategy and have potential to contribute to the knowledge base of the broader life sciences community.

Our corporate development team is ready to discuss your new product and new venture.

Contact: busdev@splpharma.com

Pipetting